Safety of in utero exposure to maternal IBD pharmacotherapies
Crossref DOI link: https://doi.org/10.1038/s41575-021-00572-9
Published Online: 2022-01-05
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Prentice, Ralley E.
Bell, Sally J.
Nold-Petry, Claudia A.
Nold, Marcel F.
Goldberg, Rimma http://orcid.org/0000-0002-4984-8585
Text and Data Mining valid from 2022-01-05
Version of Record valid from 2022-01-05
Article History
First Online: 5 January 2022
Competing interests
: The authors declare no competing interests.